Myriad Genetic Laboratories, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$7.7M
Doctors Paid
13,208
Transactions
49,567
2024 Total
$1.6M
Payment Breakdown by Category
Royalty/License$2.1M (27.6%)
Research$2.0M (26.4%)
Food & Beverage$1.5M (19.3%)
Consulting$959,480 (12.5%)
Travel$94,684 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $2.1M | 29 | 27.6% |
| Unspecified | $2.0M | 264 | 26.4% |
| Food and Beverage | $1.5M | 47,164 | 19.3% |
| Consulting Fee | $959,480 | 815 | 12.5% |
| Honoraria | $849,929 | 642 | 11.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,763 | 69 | 1.3% |
| Travel and Lodging | $94,684 | 565 | 1.2% |
| Space rental or facility fees (teaching hospital only) | $30,550 | 15 | 0.4% |
| Grant | $12,000 | 3 | 0.2% |
| Charitable Contribution | $2,850 | 1 | 0.0% |
Payments by Type
General
$5.7M
49,303 transactions
Research
$2.0M
264 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| EndoPredict Extended Endocrine Trial (EXET) | $1.1M | 3 | 158 |
| URO-013 | $319,343 | 0 | 31 |
| Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer | $290,888 | 0 | 16 |
| Tang 2 | $94,401 | 0 | 1 |
| MD01 | $87,667 | 0 | 51 |
| MDCH1 | $65,423 | 0 | 1 |
| MYRIAD PREQUEL PRENATAL SCREEN | $43,700 | 0 | 6 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Adam Cole, M.d, M.D | Anatomic Pathology & Clinical Pathology | Little Rock, AR | $207,619 | $0 |
| Dr. Adam Brufsky, Md, MD | Specialist | Pittsburgh, PA | $192,640 | $0 |
| Devesh Pandya, M.d, M.D | Hematology & Oncology | Houston, TX | $117,310 | $0 |
| Dr. Sharyn Lewin, M.d, M.D | Gynecologic Oncology | Teaneck, NJ | $115,692 | $0 |
| Dr. Alfredo Santillan-Gomez, M.d., M.p.h:, M.D., M.P.H: | Surgery | San Antonio, TX | $104,470 | $0 |
| Dr. Sucharu Prakash, Md, MD | Medical Oncology | Paris, TX | $92,874 | $0 |
| Bradley Monk, Md, MD | Gynecologic Oncology | West Palm Beach, FL | $82,216 | $0 |
| Christopher Lee, M.d, M.D | Radiation Oncology | Spokane Valley, WA | $63,046 | $0 |
| Candace Westgate, Do, DO | Obstetrics & Gynecology | Indianapolis, IN | $60,427 | $0 |
| Dr. Antonio Santillan-Gomez, M.d, M.D | Gynecologic Oncology | San Antonio, TX | $57,824 | $0 |
| Dr. Angelo Baccala, Md, MD | Urology | Allentown, PA | $48,611 | $0 |
| Dr. Shail Dalal, Md, MD | Hematology & Oncology | Palestine, TX | $42,533 | $0 |
| Dr. Thomas Krivak, Md, MD | Gynecologic Oncology | Pittsburgh, PA | $34,301 | $0 |
| Dr. John Migliano, M.d, M.D | Internal Medicine | Tucson, AZ | $33,456 | $0 |
| Dr. David Weintritt, M.d, M.D | Surgery | Alexandria, VA | $32,051 | $0 |
| Kirsten Stuber, Fnp-Bc, FNP-BC | Family | Tyler, TX | $29,404 | $0 |
| Dr. Jonathan Tward, Md, Phd, MD, PHD | Radiation Oncology | Salt Lake City, UT | $28,007 | $0 |
| Dr. Timothy Kerwin, Md, MD | Radiation Oncology | Naples, FL | $22,106 | $0 |
| Mark Edney, Md, MD | Urology | Berlin, MD | $21,607 | $0 |
| Eric Manahan, M.d, M.D | Surgery | Dalton, GA | $20,861 | $0 |
| Tina Marie Bauman, Rn, Msn, Apn, Agn-Bc, RN, MSN, APN, AGN-BC | Clinical Nurse Specialist | Barrington, IL | $17,969 | $0 |
| Dr. Todd Cohen, Md, MD | Urology | Charlotte, NC | $17,600 | $0 |
| Dr. Reagan Street, Md, MD | Obstetrics & Gynecology | Fort Worth, TX | $17,363 | $0 |
| Dario Roque, Md, MD | Gynecologic Oncology | Chicago, IL | $16,143 | $0 |
| Dr. Manoj Rao, Md, MD | Urology | Merrillville, IN | $16,057 | $0 |
Ad
Top Products
- BRAC CDX $1.0M
- PROLARIS $922,222
Associated Products (16)
- MYRISK $1.6M
- BRAC CDX $1.0M
- PROLARIS $922,222
- MYCHOICE CDX $888,409
- Prolaris $868,894
- myRisk $715,895
- EndoPredict $631,954
- PRECISETUMOR $560,527
- myChoice CDx $425,475
- PreciseTumor $97,253
- MyChoice CDx $88,009
- BRACANALYSIS CDX $83,376
- BRAC CDx $72,721
- BRACAnalysis CDx $68,672
- Prequel $43,760
- BRACAnalysis $29,878
Payment Categories
- Food & Beverage $1.5M
- Consulting $959,480
- Travel & Lodging $94,684
- Research $2.0M
- Royalties $2.1M
About Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. has made $7.7M in payments to 13,208 healthcare providers, recorded across 49,567 transactions in the CMS Open Payments database. In 2024, the company paid $1.6M. The top product by payment volume is BRAC CDX ($1.0M).
Payments were distributed across 143 medical specialties. The top specialty by payment amount is Urology ($593,941 to 3,145 doctors).
Payment categories include: Food & Beverage ($1.5M), Consulting ($959,480), Research ($2.0M), Travel & Lodging ($94,684), Royalties ($2.1M).
Myriad Genetic Laboratories, Inc. is associated with 16 products in the CMS Open Payments database, including MYRISK, BRAC CDX, and PROLARIS.